STAT January 18, 2022
Jeff Fischer

At what point do the benefits of local production of medical supplies outweigh the potentially higher cost? The sudden and near-overwhelming demand for Covid-19 testing during the Omicron phase of the pandemic means that the U.S. is now at a critical point where we need better — and quicker — access to testing supplies via a domestic supply chain.

Over the last three decades, the world’s economy has become increasingly globalized, resulting in lower inflation-adjusted prices for goods and products and improved standards of living around the world. The Covid-19 pandemic has provided an opportunity to once again debate the United States’ reliance on inexpensive overseas manufacturing, and reconsider the value of high-quality domestic production.

Specifically, the pandemic has underscored...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Govt Agencies, Healthcare System, Patient / Consumer, Provider, Public Health / COVID, Supply Chain, Technology
The AI Software Supply Chain Is A Dumpster Fire: Here's What Companies Can Do About It
Supply chain challenges in 2025: 5 things to know
As Supply Chains Go Digital, Cybersecurity Must be Strongest Link
Digital twins: The key to unlocking end-to-end supply chain growth
Why Supply Chain Technology Keeps Failing—And How To Fix It

Share This Article